BioElectronics Corporation Introduces Its New Heel Pain Product

FREDERICK, Md., Nov. 15 /PRNewswire-FirstCall/ -- BioElectronics Corporation, , announced today that it has specially designed a new ActiPatch and slipper to accommodate comfortable extended wear on the foot.

The slipper and the new patch are designed with a side pouch to affix the electronics above the ankle for extended comfortable wear. Providing for extended daytime wear improves the effectiveness of the therapy. The previous product could not be used in a weight bearing fashion.

"We believe that this new heel pain product will dramatically improve the healing time and simplify use of the product for the patient," said Andrew Whelan, President of BioElectronics.

ActiPatch(TM) is a drug-free anti-inflammatory patch with an embedded battery operated microchip that delivers weeks of continuous pulsed therapy for less than a dollar a day. The unique ActiPatch delivery system, using patented technology, provides a cost-effective, patient friendly method to reduce soft tissue pain and swelling.

For more information visit http://www.bioelectronicscorp.com

Safe Harbor Statement:

This news release contains forward-looking statements related to future growth and earnings opportunities. Such statements are based upon certain assumptions and assessments made by management of both companies in light of current conditions, expected future developments and other factors it believes to be appropriate. Actual results may differ as a result of factors over which the companies have no control.

CONTACT: Andrew J. Whelan, President & CEO of BioElectronics Corporation,
+1-301-874-4890, Fax: +1-301-874-6935, info@bioelectronicscorp.com

Web site: http://www.bioelectronicscorp.com/